By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PDI, Inc. 

Morris Corporate Center 1
Building A
300 Interpace Parkway

Parsippany  New Jersey  07054  U.S.A.
Phone: 862-207-7800 or 800-242-7494 Fax: n/a

PDI, a premier healthcare sales and marketing company, provides strategic alternatives to the portfolio challenges of biopharmaceutical and medical device and diagnostics manufacturers. Focusing on two core businesses, sales and marketing services and product commercialization, PDI leverages its expertise to maximize profitable brand growth.

PDI built its reputation as a market leader delivering innovative solutions, extraordinary service and superior results. Offering four strategic sales force solutions, recruitment services, marketing research, and medical education programs, PDI continues to meet the ever-changing needs of the industry. Deployed independently or in combination, these services leverage our pioneering outsourcing expertise into next-generation sales and marketing services, promoting maximum profitable brand sales growth. PDI also maintains a global presence through a strategic partnership with In2Focus, a leading European outsourced sales company.

Backed by the strength of a comprehensive commercial infrastructure, PDI responds to the needs of clients of all sizes, providing an outsourced infrastructure to small and emerging pharmaceutical manufacturers with limited resources, as well as strategic alternatives for larger manufacturers with products that no longer meet their strategic intent.

For all of its clients and partners, PDI's commitment remains constant: to deliver passion, integrity, innovation, excellent execution and superior results to the biopharmaceutical and medical device and diagnostics industry.

For more information, visit PDI's Website at

Last Updated: 03-30-04

Key Statistics

Ownership: Public

Web Site: PDI, Inc.
Symbol: PDII


Company News
PDI, Inc. (PDII) Subsidiary Interpace Diagnostics Announces New Data Supporting Use of ThyraMIR - First And Only Microrna Gene Expression Classifier - With ThyGenX Thyroid Oncogene Panel To Improve Identification Of Both Benign And Malignant Thyroid Nodules 3/9/2015 7:49:58 AM
PDI, Inc. (PDII) To Present At The 27th Annual ROTH Conference 3/5/2015 10:57:43 AM
PDI, Inc. (PDII) Reports Fourth Quarter And Full Year 2014 Financial Results 3/4/2015 7:54:50 AM
PDI, Inc. (PDII) To Hold Fourth Quarter And Full Year 2014 Financial Results Conference Call On Tuesday, March 3, 2015 2/17/2015 10:38:39 AM
PDI, Inc. (PDII) Subsidiary Interpace Diagnostics Announces Launch Of ThyGenX Next-Generation Sequencing (NGS) Test For Cancer Risk Assessment Of Thyroid Nodules 12/17/2014 9:11:00 AM
PDI, Inc. (PDII) Reports 2014 Third Quarter Financial Results; Acquires RedPath Integrated Pathology, Inc. 11/3/2014 8:16:20 AM
PDI, Inc. (PDII) Rejects Digirad Corporation (DRAD) Buyout Offer, Snags RedPath Integrated Pathology, Inc. Instead 11/3/2014 7:31:24 AM
Digirad Corporation (DRAD) Delivers Letter To PDI, Inc. (PDII) Expressing Willingness To Acquire Company At A Premium To Market For A Combination Of Cash And Stock Of Digirad 10/31/2014 8:45:48 AM
Digirad Corporation (DRAD) Delivers Letter To PDI, Inc. (PDII) Responding To PDI's Summary Rejection Of Digirad's Offer To Acquire Company 10/31/2014 8:28:18 AM
PDI, Inc. (PDII) Announces Date & Time Change For Third Quarter Financial Results Conference Call 10/31/2014 8:05:07 AM